Telomerase activity in effusions: A comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 12, 2008, Pages 1896-1902

  Hansson, Maire ^a   Zendehrokh, Nooreldin ^a   Ohyashiki, Junko ^b   Ohyashiki, Kazuma ^b   Westman, Ulla Britt ^c   Roos, Göran ^c   Dejmek, Annika ^a  

^a LUND UNIVERSITY   (Sweden)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; ASCITES; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MESOTHELIUM CELL; OUTCOME ASSESSMENT; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ASCITIC FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MESOTHELIOMA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PERICARDIAL EFFUSION; PERITONEAL NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TELOMERASE; TELOMERE;

EID: 57349123276     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
2. Piatyszek MA, Kim NW, Weinrich SL, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci. 1995;17:1-15.
3. Lee W-Y. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Cytopathology. 2005;16:227-232.
4. Mu XC, Brien TP, Ross JS, Lowry CV, McKenna BJ. Telomerase activity in benign and malignant cytologic fluids. Cancer (Cancer Cytopathol). 1999;87:93-99.
5. Hess JL, Highsmith WE. Telomerase detection in body fluids. Clin Chem. 2002;48:18-24.
6. Cunningham V, Markham N, Shroyer AL, Shroyer KR. Detection of telomerase expression in fine-needle aspirations and fluids. Diagn Cytopathol. 1998;18:431-436.
7. Toshima S, Arai T, Yasuda Y, et al. Cytological diagnosis and telomerase activity of cells in effusions of body cavities. Oncol Rep. 1999;6:199-203.
8. Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol. 1998;16:567-573.
9. Tangkijvanich P, Tresukosol D, Sampatanukul P, et al. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res. 1999;5:2470-2475.
10. Murakami J, Nagai N, Ohama K. Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer. J Int Med Res. 1998;26:129-139.
11. Braunschweig R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of telomerase assay and cytological examination. Diagn Cytopathol. 2001;24:174-180.
12. Braunschweig R, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, Benhattar J. Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol. 2001;25:225-230.
13. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res. 1997;57:2100-2103.
14. Dejmek A, Yahata N, Ohyashiki K, et al. In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol. 2000;24:11-15.
15. Zendehrokh N, Dejmek A. Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes. Mod Pathol. 2005;18:189-196.
16. Dejmek A, Hjerpe A. The combination of CEA, EMA and BerEp4, and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion. Diagn Cytopathol. 2005;32:160-166.
17. Nurminen M, Dejmek A, Martensson G, Thylen A, Hjerpe A. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin Chem. 1994;40:777-780.
18. Counter CM, Gupta J, Harley CB, Leger B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320.
19. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood. 1996;88:222-229.
20. Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology. 2002;7(3):171-191.